Ted Snelgrove

Ted Snelgrove is the Chief Executive Officer of FormaPath, Inc., a company focused on developing and commercializing innovative tools for tissue labs in anatomic pathology.12

Professional Background

Ted is a diagnostics industry veteran with extensive experience in oncology, reproductive medicine, and value-based pricing.2 He has been leading new companies in the life science sector in C-level roles for over 20 years, with a background spanning BioPharma Rx, Dx, and medical devices.4

Current Role at FormaPath

As CEO of FormaPath, Ted is spearheading a revolution in anatomic pathology (AP) labs to automate tissue management and align with digital pathology advancements.3 The company is working in close partnership with Mayo Clinic to develop novel technology for anatomic pathology labs.1

Company Mission

Under Ted's leadership, FormaPath is on a mission to:

1. Improve turnaround time in tissue labs
2. Enhance sample quality
3. Increase consistency through automation2

The ultimate goal is to equip treatment teams with comprehensive, accurate staging data, thereby improving patient care.2

Recent Developments

FormaPath recently launched AdiPress, a product designed for lymph node processing in anatomic pathology labs.6 This innovation aligns with the company's focus on modernizing lab operations and improving data quality.1

Education

Ted Snelgrove holds a degree from the University of Michigan.5

For those interested in connecting with Ted or learning more about FormaPath, he is active on LinkedIn and can be reached through the company's website at formapath.com.1